Conclusion not excluding drug discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient Denosumab Prolia (ATC code according to WHO: M05BX04)
By: AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA📍 GermanyOpen
Key Information
| Reference | GB-451344-2026 |
|---|
| Deadline | May 31, 2027 12:00 AM |
|---|
| Competition Type | NCB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Germany |
|---|
| Address | City : Erfurt
Postal code : 99084
Telephone : +49 80010590-80071
Country : Germany |
|---|
| Published | Jul 1, 2026 |
|---|
Description
<br/>The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicines with the active ingredient denosumab (ATC co...
Full details are available after unlocking this tender.